SCHMERTZLER MICHAEL

Average Profitability
49.41%
Insider Buys Quantity
6
Insider Buys Sum
$17.21M
Insider Sells Quantity
10
Insider Sells Sum
$6.41M

Insider Activity of SCHMERTZLER MICHAEL

According to the SEC Form 4 filings, SCHMERTZLER MICHAEL, being in a position of

  1. director at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1500 shares for $41,715,
    over all time since 2013-03-07, has bought 911841 share for $11.21M, and sold 2500 shares for $86,575.

The largest purchase of all time was on 2013-06-25 and amounted to 533333 shares of PTC Therapeutics, Inc. for $8M.

The largest sale of all time was on 2010-05-18 and amounted to 829176 shares of Cytokinetics, Incorporated for $2.49M.

Biography of SCHMERTZLER MICHAEL

No biography is available at this moment.

2024-01-08SalePTC Therapeutics, Inc.
PTCT
director
1,500
0.0019%
$27.81$41,715+8.48%
2023-06-07SalePTC Therapeutics, Inc.
PTCT
director
1,000
0.0014%
$44.86$44,860-34.47%
2020-03-16PurchasePTC Therapeutics, Inc.
PTCT
director
20,000
0.0322%
$32.48$649,692+60.5%
2019-01-25PurchasePTC Therapeutics, Inc.
PTCT
director
66,225
0.1217%
$30.20$2M+38.99%
2014-02-19PurchasePTC Therapeutics, Inc.
PTCT
23,000
0.0806%
$24.50$563,500+12.68%
2013-06-25PurchasePTC Therapeutics, Inc.
PTCT
533,333
1.9161%
$15.00$8M+8.52%
2013-03-07PurchasePTC Therapeutics, Inc.
PTCT
269,283
$0$0
2010-06-03SaleCytokinetics, Incorporated
CYTK
director
10,764
0.0169%
$3.00$32,292-27.76%
2010-05-27SaleCytokinetics, Incorporated
CYTK
director
115,216
0.1805%
$3.00$345,648-27.33%
2010-05-19SaleCytokinetics, Incorporated
CYTK
director
32,478
0.0516%
$3.00$97,434-25.34%
2010-05-18SaleCytokinetics, Incorporated
CYTK
director
829,176
1.3037%
$3.00$2.49M-25.75%
2010-05-12SaleCytokinetics, Incorporated
CYTK
director
165,476
0.2576%
$3.00$496,428-26.16%
2010-05-11SaleCytokinetics, Incorporated
CYTK
director
73,000
0.1159%
$3.00$219,000-24.66%
2010-05-06SaleCytokinetics, Incorporated
CYTK
director
66,892
0.1069%
$3.03$202,683-24.92%
2010-05-05SaleCytokinetics, Incorporated
CYTK
director
804,200
1.277%
$3.04$2.44M-25.33%
2009-05-21PurchaseCytokinetics, Incorporated
CYTK
director
3.05M
5.7448%
$1.97$6M+68.65%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.